Subscribe to Free Daily Newsletters
Post a Job

Featured Jobs

Executive Director

Employers Council on Flexible Compensation (ECFC)
(Washington DC / Telecommute)
MEP Assistant Team Leader

Nova 401(k) Associates
(Houston TX / Dallas TX / Austin TX / Scottsdale AZ / Telecommute)
Employee Benefits (ERISA) Associate Attorney

Stinson LLP
(Kansas City MO / Minneapolis MN)
Senior Retirement Plan Administrator

RetireWell Administrators, Inc.
(Marlton NJ / Telecommute)
401(k) Plan Administrator
Southern Pension Services
(Tampa FL)
Relationship Manager

Benefit Plans Plus, LLC [BPP]
(Saint Louis MO / Edwardsville IL / Henderson KY)

Free Daily News and Jobs

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Get the BenefitsLink app LinkedIn
Twitter
Facebook

News Items, by Subject (Headlines)

Health plan costs - prescription drugs


Now Viewing Headlines View Excerpts and
Headlines

Stemming the Rising Costs of Prescription Drugs: Pharmacy Benefit Managers
Stemming the Rising Costs of Prescription Drugs: Public Health Plans
[Opinion] What Can the U.S. Learn from Rx Spending Controls in France?
How to Do External Reference Pricing
Medicare Increase in Prescription Drug Spending More Than Offsets Lower Beneficiary Costs for Other Services
Drug Spending Is Reducing Health Care Costs
California's New Transparency Law Reveals 8% Increase in Wholesale Drug Prices
[Guidance Overview] Extreme Couponing: How Manufacturer Coupons Impact Health Plans
Study Finds Dramatic Increase in Antidepressant Use by Individuals with Employer-Sponsored Insurance
Keeping Score: Specialty Drug Per Employee Cost Trend
Real-Time Benefit Tools for Drug Prices
[Guidance Overview] The Uncertain Status of Prescription Drug Copay Accumulator Programs
Comparison of Proposals to Control Drug Prices
Part D Cost for Brand Name Drugs Rising
Small Businesses See Prescription Drug Costs as Main Factor in Health Insurance Affordability
Report to Congress: Prescription Drugs: Innovation, Spending, and Patient Access
Report to Congress: Prescription Drug Pricing
Assessing Drug Price Increases in Medicare Part D and the Implications of Inflation Limits
58 Percent of Local Pharmacies May Close in Next Two Years (PDF)
U.S. Public's Perspective on Prescription Drug Costs
How Will the Medicare Part D Benefit Change Under Current Law and Leading Proposals?
Variation in U.S. Private Health Plans' Coverage of Orphan Drugs
[Opinion] Importing Lower-Cost Prescription Drugs to Support Public Health Services
A Painful Pill to Swallow: U.S. vs. International Prescription Drug Prices (PDF)
House Speaker Pelosi Unveils Bill to Lower Prescription Drug Prices
Wasteful Drug Spending Contributes to High Prescription Costs
2020 Global Medical Trend Rates Report
[Guidance Overview] Two Interesting New Rules Regarding Prescription Drugs -- What Is Really Going On?
Eliminating Pharmacy Waste -- It's Not Easy
Pharma CEOs Shower GOP Senators with Campaign Cash
Reducing Wasteful Spending in Employers' Pharmacy Benefit Plans
Plans Need Not Count Drug Manufacturer Coupons Toward the ACA's Cost-Sharing Annual Limits
[Guidance Overview] 2020 Drug Coupon Rule Dropped Due to Implementation Concerns
HHS Walks Back New Policy on Drug Coupons
The New Hospital Price Disclosure Rule Is Important, But Only a First Step
Administration Again Attempts to Lower Drug Prices
Maximizing a Pharmacy Benefit Program: Innovative Solutions for Employers
Shopping Abroad for Cheaper Medication? Here's What You Need To Know
Amazon Mail-Order Pharmacy Faces Pushback
Follow the Scripts: Trends in ERISA Litigation Against PBMs
Drug Pricing and Surprise Billing: Recent Actions and Outlook
Congress and Administration Consider Significant Drug Pricing Policy Changes
Administration Announces Plan to Permit Drug Importation
Trump Administration 'Open for Business' on Drug Imports from Canada
[Official Guidance] HHS Announces New Action Plan to Lay Foundation for Safe Importation of Certain Prescription Drugs
Medicare Part D Prescription Drug Plan Costs to Decline Again in 2020
Policy Options for Addressing High Drug Prices
[Opinion] Drug Rebates Will Remain, But So Will Pressure to Reduce Drug Prices and Demonstrate Value
A Small Group of Patients Facing High Drug Costs Drive Health Care Spending
Prescription Drug Rebates, Explained
Understanding the Senate Finance Committee's Drug Pricing Package
Is Prescription Drug Pricing the Cure for Partisanship?
Senate Finance Committee Passes Drug Pricing Package
Senate Finance Committee Unveils Bipartisan Bill to Lower Drug Costs
Senate Hearings On Drug Prices: Many Questions, Few (Useful) Answers
Rising Generic Prices Help Drive Up Cost of WHO List of Essential Medicines in US
[Opinion] There Is No Single, Best Policy for Drug Prices
How Blockchain Technology Will Disrupt the PBM-Payer-Pharmacy Relationship
Administration Drops Plan to Curb Drug Rebates
Will Prescription Drug Price Disclosures Have an Impact?
© 2019 BenefitsLink.com, Inc.